1 / 8

Hormone Replacement Therapy (HRT) Market – Trends Forecast Till 2030

Hormone Replacement Therapy (HRT) Market, By Product (Estrogen & Progesterone Replacement Therapy), By Route of Administration, By Disease Type and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Mayuri24
Download Presentation

Hormone Replacement Therapy (HRT) Market – Trends Forecast Till 2030

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hormone Replacement Therapy (HRT) Market Trends, Size, Share, Demands, Overview, Growth, Revenue and Forecast to 2030 sales@delvens.comwww.delvens.com

  2. Sternal Closure Systems Market – Trends Forecast Till 2030 Hormone Replacement Therapy (HRT) Market, By Product (Estrogen & Progesterone Replacement Therapy), By Route of Administration, By Disease Type and Region (North America, Europe, Asia-Pacific, Middle East and Africa and South America). Request For Free Sample Report: https://www.delvens.com/get-free-sample/homeland-security-and-emergency-management-market sales@delvens.com www.delvens.com

  3. Market Overview Hormone replacement therapy is used when the human body is not able to produce enough hormones. It is used for the treatment of menopause, hypothyroidism, male hypogonadism, and growth hormone deficiency conditions. The signs that the individual requires hormone replacement therapy are hot flashes, night sweats, vaginal dryness, pain, itching, or burning during intercourse, bone loss, low sex drive, mood changes, and irritability. The increasing prevalence of chronic conditions such as hypogonadism in adult men worldwide is expected to drive the growth of the hormone replacement therapy market. Furthermore, another major factor fuelling the growth of the market is the ease of access to hormonal replacement therapy and government support for research and development activities for hormonal replacement therapy drugs. Purchase this Report: https://www.delvens.com/checkout/hormone-replacement-therapy-hrt-market sales@delvens.com www.delvens.com

  4. Key Findings The Hormone Replacement Therapy (HRT) Market is segmented into product, route of administration, disease type, and region: The product segment is further fragmented into Estrogen and Progesterone Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Replacement Therapy, and Parathyroid Hormone Replacement. The route of administration segment is further fragmented into Oral, Parenteral, Transdermal, and Others. sales@delvens.com www.delvens.com

  5. Key Findings The disease segment is further fragmented into Menopause, Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, and Hypoparathyroidism. The menopause segment dominated the market and is anticipated to maintain its dominance during the forecast period. The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is estimated to account for the largest market share during the forecast period. Inquire Before Buying: https://www.delvens.com/Inquire-before-buying/hormone-replacement-therapy-hrt-market sales@delvens.com www.delvens.com

  6. Competitive Landscape • Novartis AG • Abbott Laboratories • Mylan N.V. • Merck KgaA • Bayer AG • Pfizer Inc. • Novo Nordisk A/S • QuatRx Pharmaceuticals • Teva Pharmaceutical Industries Ltd. • Amgen, Inc. • Eli Lilly and Company sales@delvens.com www.delvens.com

  7. Recent Developments May 2021 – Myovant Sciences GmbH announced that it received approval from the U.S. FDA for its hormone therapy Myfembree as a treatment for uterine fibroid bleeding. The drug launched by Myovant will give direct competition to AbbVie with an added dosing advantage. April 2021 – TherapeuticsMD, Inc. and Theramex announced that they received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) and Federal Agency of Medicines and Health Products (FAMHP) for the use of BIJUVE in the U.K and under BIJUVA trade name in Belgium. The capsule will be used as hormone replacement therapy. sales@delvens.com www.delvens.com

  8. Contact Information About Us: Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally. Contact Us: +44-20-3290-6466 +1 214-377-1144 sales@delvens.com sales@delvens.com www.delvens.com

More Related